Philip M Kelley,Richard M Tempero
Philip M Kelley
The structural and molecular properties of the human tonsil lymphatic microvascular system are important to understand as these features likely contribute to fluid balance, immunity, and tumor metastasis. The tonsil is a unique lymphoid org...
Assessment of volume measurement of breast cancer-related lymphedema by three methods: circumference measurement, water displacement, and dual energy X-ray absorptiometry [0.03%]
三种方法评估乳腺癌相关淋巴水肿体积测量的准确性：围长测量、水置换和双能量X线吸收法
Caroline Gjorup,Bo Zerahn,Helle W Hendel
Caroline Gjorup
Background: Following treatment for breast cancer 12%-60% develop breast cancer-related lymphedema (BCRL). There are several ways of assessing BCRL. Circumference measurement (CM) and water displacement (WD) for volume me...
Comparative Study
Lymphatic research and biology. 2010 Jun;8(2):111-9. DOI:10.1089/lrb.2009.0016 2010
Lymphatic pump treatment mobilizes leukocytes from the gut associated lymphoid tissue into lymph [0.03%]
淋巴泵治疗可使肠道相关淋巴组织中的白细胞进入淋巴液中
Lisa M Hodge,Melissa K Bearden,Artur Schander et al.
Lisa M Hodge et al.
Background: Lymphatic pump techniques (LPT) are used clinically by osteopathic practitioners for the treatment of edema and infection; however, the mechanisms by which LPT enhances lymphatic circulation and provides prote...
Stanley G Rockson
Stanley G Rockson
The biochemistry, chemistry and physiology of the isoflavones in soybeans and their food products [0.03%]
大豆及其食品中的异黄酮的生化、化学及生理学
Stephen Barnes
Stephen Barnes
In this review of the chemistry, absorption, metabolism, and mechanisms of action of plant isoflavones, emphasis is placed on the isoflavones in soy and the food products derived from them. Soybeans have been part of food history in Asia fo...
The International LAM Registry: a component of an innovative web-based clinician, researcher, and patient-driven rare disease research platform [0.03%]
国际性LAM注册中心：一个创新的基于网络的临床医生、科研人员和患者驱动型罕见病研究平台的一部分
Michael Nurok,Ian Eslick,Carlos R R Carvalho et al.
Michael Nurok et al.
Background: A relative inability to capture a sufficiently large patient population in any one geographic location has traditionally limited research into rare diseases. ...
Clinical trials for rare lung diseases: lessons from lymphangioleiomyomatosis [0.03%]
罕见肺疾病临床试验的研究教训——淋巴管肌瘤病的启示
Brent Kinder,Francis X McCormack
Brent Kinder
Lymphangioleiomyomatosis (LAM) is a rare, slowly progressive neoplasm that causes gradual but often life-threatening cystic destruction of the lung. Advances in our understanding of the molecular and cellular pathogenesis have LAM have iden...
Thomas N Darling,Gustavo Pacheco-Rodriguez,Alfredo Gorio et al.
Thomas N Darling et al.
The cells comprising pulmonary lymphangioleiomyomatosis (LAM) and renal angiomyolipomas (AMLs) are heterogeneous, with variable mixtures of cells exhibiting differentiation towards smooth muscle, fat, and vessels. Cells grown from LAM and A...
Animal models of lymphangioleiomyomatosis (LAM) and tuberous sclerosis complex (TSC) [0.03%]
淋巴管平滑肌瘤病(LAM)和结节性硬化症(TSC)的动物模型
David J Kwiatkowski
David J Kwiatkowski
Animal models of lymphangioleiomyomatosis (LAM) and tuberous sclerosis complex (TSC) are highly desired to enable detailed investigation of the pathogenesis of these diseases. Multiple rats and mice have been generated in which a mutation s...
mTOR activation, lymphangiogenesis, and estrogen-mediated cell survival: the "perfect storm" of pro-metastatic factors in LAM pathogenesis [0.03%]
mTOR活化、淋巴管生成和雌激素介导的细胞存活：“完美风暴”——肺淋巴管肌瘤病促转移因素
Jane Yu,Elizabeth Petri Henske
Jane Yu
Research interest in lymphangioleiomyomatosis (LAM) has grown dramatically in the past decade, particularly among cancer biologists. There are at least two reasons for this: first, the discovery in the year 2000 that LAM cells carry TSC2 ge...